TD Ameritrade Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-47
| Closed | -$17K | – | 497 |
|
|
2023
Q2 | $17K | Sell |
47
-19
| -29% | -$6.87K | ﹤0.01% | 301 |
|
|
2023
Q1 | $21K | Sell |
66
-31
| -32% | -$9.86K | ﹤0.01% | 302 |
|
|
2022
Q4 | $28K | Buy |
+97
| New | +$28K | ﹤0.01% | 297 |
|
|
2022
Q3 | – | Sell |
-268
| Closed | -$76K | – | 635 |
|
|
2022
Q2 | $76K | Sell |
268
-253
| -49% | -$71.7K | ﹤0.01% | 268 |
|
|
2022
Q1 | $136K | Sell |
521
-30
| -5% | -$7.83K | ﹤0.01% | 267 |
|
|
2021
Q4 | $121K | Buy |
+551
| New | +$121K | ﹤0.01% | 279 |
|
|
2021
Q3 | – | Sell |
-457
| Closed | -$92K | – | 704 |
|
|
2021
Q2 | $92K | Buy |
+457
| New | +$92K | ﹤0.01% | 288 |
|
|
2019
Q3 | – | Sell |
-21
| Closed | -$4K | – | 725 |
|
|
2019
Q2 | $4K | Hold |
21
| – | – | ﹤0.01% | 523 |
|
|
2019
Q1 | $4K | Sell |
21
-51
| -71% | -$9.71K | ﹤0.01% | 479 |
|
|
2018
Q4 | $12K | Buy |
72
+47
| +188% | +$7.83K | ﹤0.01% | 334 |
|
|
2018
Q3 | $5K | Buy |
25
+5
| +25% | +$1K | ﹤0.01% | 409 |
|
|
2018
Q2 | $3K | Buy |
+20
| New | +$3K | ﹤0.01% | 318 |
|